Related references
Note: Only part of the references are listed.Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Changes in MIC Within a Global Collection of Acinetobacter baumannii Collected as Part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009
Rayo Morfin-Otero et al.
CLINICAL THERAPEUTICS (2012)
Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010
Anne Marie Queenan et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii
Nabil Karah et al.
DRUG RESISTANCE UPDATES (2012)
Role of Acinetobactin-Mediated Iron Acquisition Functions in the Interaction of Acinetobacter baumannii Strain ATCC 19606T with Human Lung Epithelial Cells, Galleria mellonella Caterpillars, and Mice
Jennifer A. Gaddy et al.
INFECTION AND IMMUNITY (2012)
Surface-associated motility, a common trait of clinical isolates of Acinetobacter baumannii, depends on 1,3-diaminopropane
Evelyn Skiebe et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
Yun Cai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Acinetobacter baumannii virulence is enhanced in Galleria mellonella following biofilm adaptation
Matthew E. Wand et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Identification of a General O-linked Protein Glycosylation System in Acinetobacter baumannii and Its Role in Virulence and Biofilm Formation
Jeremy A. Iwashkiw et al.
PLOS PATHOGENS (2012)
In Vivo Efficacy of Glycopeptide-Colistin Combination Therapies in a Galleria mellonella Model of Acinetobacter baumannii Infection
M. Hornsey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Genomic Analysis of the Multidrug-Resistant Acinetobacter baumannii Strain MDR-ZJ06 Widely Spread in China
Hua Zhou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
Luis A. Arroyo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System
Alejandro Beceiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen
Ryan K. Shields et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity
Luisa C. S. Antunes et al.
PLOS ONE (2011)
Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii
N. C. Gordon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Acinetobacter baumannii 2002-2008: Increase of Carbapenem-Associated Multiclass Resistance in the United States
Robertino M. Mera et al.
MICROBIAL DRUG RESISTANCE (2010)
Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and Therapeutics
Anton Y. Peleg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
Mark D. Adams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A peptidomics study reveals the impressive antimicrobial peptide arsenal of the wax moth Galleria mellonella
Susan E. Brown et al.
INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Acinetobacter: an old friend, but a new enemy
K. J. Towner
JOURNAL OF HOSPITAL INFECTION (2009)
Extensively Drug-Resistant Acinetobacter baumannii
Yohei Doi et al.
EMERGING INFECTIOUS DISEASES (2009)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Purification and characterization of eight peptides from Galleria mellonella immune hemolymph
Malgorzata Cytrynska et al.
PEPTIDES (2007)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Microextraction of bacterial lipid A: easy and rapid method for mass spectrometric characterization
A El Hamidi et al.
JOURNAL OF LIPID RESEARCH (2005)
Superoxide production in Galleria mellonella hemocytes:: Identification of proteins homologous to the NADPH oxidase complex of human neutrophils
D Bergin et al.
INFECTION AND IMMUNITY (2005)
Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains
A Novelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
